SCHEMBL25964137

SCHEMBL25964137

CCCCCCCCC(CCCCCC)CON

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
OPRM1 P35372 1/20 0.42
SPHK1 Q9NYA1 2/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
DNM1 Q05193 2/20 0.39
CYP3A4 P08684 2/20 0.38
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
CYP2D6 P10635 2/20 0.38
PLA2G1B P04054 1/20 0.38
PLA2G2A P14555 1/20 0.38
GMNN O75496 1/20 0.38
POLB P06746 1/20 0.38
THPO P40225 1/20 0.38
MTOR P42345 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23308783 0.98 LMNA (0.48) LMNAOPRM1SPHK1ADRB2ADRB1
SCHEMBL7530776 0.81 CYP3A4 (0.57) LMNAOPRM1ADRB2ADRB1ADRB3
SCHEMBL8387794 0.80 LMNA (0.54) LMNAOPRM1ALDH1A1DNM1CYP3A4
SCHEMBL574982 0.80 LMNA (0.54) LMNAOPRM1ALDH1A1DNM1CYP3A4
SCHEMBL2188453 0.80 LMNA (0.54) LMNAOPRM1ALDH1A1DNM1CYP3A4
SCHEMBL20253212 0.80 LMNA (0.54) LMNAOPRM1ALDH1A1DNM1CYP3A4
SCHEMBL1776604 0.80 LMNA (0.54) LMNAOPRM1ALDH1A1DNM1CYP3A4
SCHEMBL18327083 0.80 LMNA (0.54) LMNAOPRM1ALDH1A1DNM1CYP3A4
SCHEMBL21641724 0.80 LMNA (0.54) LMNAOPRM1ALDH1A1DNM1CYP3A4
SCHEMBL20394323 0.80 LMNA (0.54) LMNAOPRM1ALDH1A1DNM1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144798-A1 IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES GENEVANT SCIENCES GMBH (CH) 2023-08-03 WO disclosed